Comment period closing · Centers for Disease Control and Prevention · Jul 27CDCClosedAdvancing Violence Epidemiology in Real-Time (AVERT) 2026-10513
Bill introduced · Jul 27A bill to establish a Green New Deal for Health to prepare and empower the health care sector to protect the health and well-being of our workers, our communities, and our planet in the face of the climate crisis, and for other purposes.
Bill introduced · Jul 27To direct the Federal Trade Commission to conduct an investigation and submit to Congress a report on unfair or deceptive acts or practices that may be prevalent in the advertising or marketing of preterm infant formula and to issue regulations to prohibit unfair or deceptive acts or practices related to the advertising or marketing of preterm infant formula, and for other purposes.
Comment period closing · Environmental Protection Agency · Jul 25EPAClosedRevisions to Establish the Sixth Unregulated Contaminant Monitoring Rule (UCMR 6) for Public Water Systems
Comment period closing · Centers for Disease Control and Prevention · Jul 25CDCClosedOrder Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right to Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists
Comment period closing · Centers for Medicare & Medicaid Services · Jul 24CMSClosedPrivacy Act; Matching Program
Notice · Environmental Protection Agency · Jul 23EPAOpening Statement_Proposed 2006 PM2.5 Harrisburg-York Area Second Maintance Plan_Public Hearing
Bill introduced · Jul 23A bill to direct the Secretary of Health and Human Services to study and report on the state of men's health in the United States and to establish an Office of Men's Health within the Department of Health and Human Services.
Bill introduced · Jul 23A bill to prohibit the award of Federal education funds to educational institutions and agencies that do not allow for religious exemptions to vaccination requirements, and for other purposes.
Bill introduced · Jul 23To require the coverage of testing for certain sexually transmitted infections without the imposition of cost sharing, and for other purposes.
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0192 - One Generation Reproduction Study of PFOS in Rats - Pharmacokinetic Analysis Study Outline (List of Section Attachments is first page in this file)
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0190 - Determination of Perfluorooctane Sulfonate (PFOS), Perfluorooctane Sulfonylamide (PFOSA), and Perflurooctanoate (PFOA) in Water by Liquid-Solid Extraction and High-Performance Liquid Chromatography/Tandem Mass Spectrometry (HPLC/MS/MS)
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0179 - Protocol for Study No. T-6295,16 DT-31: Low Level PFOS Dose versus Rat Serum and Liver PFOS (List of Section Attachments is first page of this file)
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0178 - Analytical Reports of Data for Fluorochemical Analysis in Human Sera
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0176 - Analysis of Serum Values in Decatur Workers
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0175 - Antwerp Blood Testing Results from June 1995
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0168 - Covence Studies, report on assessment of mitochondrial bioenergetics
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0160 - Letter sent via Facsimile to EPA (Jennifer Seed) submitting Analytical Data (serum measurements) from 2 Studies
Notice · Environmental Protection Agency · Jul 22EPAAR-226-0153 - Submitted as CBI: Exploratory 28- Day Oral Toxicity Study with Telomer Alsohol, Telomer Acrylate, PFBS, PFHS and PFOS (positive control) by Daily Gavage in the Rat followed by a 14/28-Day Recovery Period (Submitted as a separate FYI)